- Previous Close
0.0300 - Open
0.0240 - Bid 0.0250 x --
- Ask 0.0422 x --
- Day's Range
0.0240 - 0.0240 - 52 Week Range
0.0232 - 0.1090 - Volume
29,500 - Avg. Volume
14,017 - Market Cap (intraday)
5.225M - Beta (5Y Monthly) 2.62
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
www.nugenmd.comRecent News: 79O.F
View MorePerformance Overview: 79O.F
Trailing total returns as of 4/1/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 79O.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 79O.F
View MoreValuation Measures
Market Cap
6.33M
Enterprise Value
12.73M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.75
Price/Book (mrq)
--
Enterprise Value/Revenue
25.84
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-33.95%
Return on Equity (ttm)
--
Revenue (ttm)
762.79k
Net Income Avi to Common (ttm)
-8.31M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
9.34M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.56M